These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Prevention of cytomegalovirus infection after organ transplantation with passive immunization. An analysis of 6 randomized clinical trials. Metselaar H; Weimar W Beitr Infusionsther; 1992; 30():198-202. PubMed ID: 1284706 [TBL] [Abstract][Full Text] [Related]
14. Progress toward developing a cytomegalovirus vaccine. Marshall GS; Plotkin SA Infect Dis Clin North Am; 1990 Jun; 4(2):283-98. PubMed ID: 2161034 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus vaccines: current status. Starr SE Infect Agents Dis; 1992 Jun; 1(3):146-8. PubMed ID: 1365538 [TBL] [Abstract][Full Text] [Related]
16. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413 [TBL] [Abstract][Full Text] [Related]
17. Fetal effects of primary and non-primary cytomegalovirus infection in pregnancy: are we close to prevention? Ornoy A Isr Med Assoc J; 2007 May; 9(5):398-401. PubMed ID: 17591385 [TBL] [Abstract][Full Text] [Related]
18. CMV seroconversion in pregnants and the incidence of congenital CMV infection. Satilmiş A; Güra A; Ongun H; Mendilcioğlu I; Colak D; Oygür N Turk J Pediatr; 2007; 49(1):30-6. PubMed ID: 17479641 [TBL] [Abstract][Full Text] [Related]
19. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376 [TBL] [Abstract][Full Text] [Related]